AORT vs ENOV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 02, 2026

AORT

47.3
AI Score
VS
ENOV Wins

ENOV

49.7
AI Score

Investment Advisor Scores

AORT

47score
Recommendation
HOLD

ENOV

50score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric AORT ENOV Winner
Revenue 116.34M 589.15M ENOV
Net Income 1.42M -8.76M AORT
Gross Margin 64.9% 62.0% AORT
Net Margin 1.2% -1.5% AORT
Operating Income 5.79M 6.53M ENOV
ROE 0.3% -0.6% AORT
ROA 0.2% -0.2% AORT
Total Assets 883.16M 3.83B ENOV
Cash 55.76M 33.13M AORT
Debt/Equity 0.48 0.90 AORT
Current Ratio 3.86 2.04 AORT
Free Cash Flow -6.85M -28.85M AORT

Relative Price Performance (Last 90 Days)

AORT 1M: +13.9% · 3M: -25.1% ENOV 1M: +45.5% · 3M: +24.4%

Current Technical Phase

AORT

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 62

RSI (14): 61.5 · Price: $26.83

ENOV

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (3.9% over 20 days), RSI 62

RSI (14): 62.1 · Price: $29.15

Fundamentals Snapshot

Metric AORT ENOV
Market Cap
Forward P/E 37.3 7.1
Trailing P/E 110.7
Revenue (TTM)
Revenue Growth 0.2% 0.1%
Gross Margin 0.6% 0.6%
Operating Margin 0.1% 0.0%
EPS 0.25 -19.89
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, ENOV is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.